Treatment of CD34+ CP-CML cells with LDN or DOR ±IM resulted in downregulation of BMP-related genes, especially the SMAD and SMURF family of genes. The gene discussed is CP; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.